Chris T. Bitterman - Vice Pres Sales & Marketing at Cumberland Pharmaceuticals Inc

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Options (right to buy)	13.3K	$22.7K	$1.71	Mar 25, 2024	Direct	Common Stock
Common Stock	4.68K	$8.48K	$1.81	Mar 23, 2024	Direct

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.